Concepedia

Hojong Yoon

HY

Statistics

Publications

19

Citations

1K

H-Index

15

Active since

2014

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Broad Institute

Korea Institute of Science and Technology

Brigham and Women's Hospital

Hojong Yoon is an author at Dana-Farber Cancer Institute specializing in molecular biology, drug discovery, and life sciences.

ORCID

Publications per year

2014–2025

19

Publications

19

Small-molecule-induced polymerization triggers degradation of BCL6

Mikołaj Słabicki, Hojong Yoon, Jonas Koeppel et al. · Nature · 2020 · 270 citations · Full text

, , +3

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15

T.B. Faust, Hojong Yoon, Radosław P. Nowak et al. · Nature Chemical Biology · 2019 · 211 citations · Full text

, , +13

Template-assisted covalent modification underlies activity of covalent molecular glues

Yen-Der Li, W Michelle, Muhammad Murtaza Hassan et al. · Nature Chemical Biology · 2024 · 91 citations · Full text

, , +10

Exploring the target scope of KEAP1 E3 ligase-based PROTACs

Guangyan Du, Jie Jiang, Nathaniel J. Henning et al. · Cell chemical biology · 2022 · 90 citations · Full text

, , +7

Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface

Mingxing Teng, Scott B. Ficarro, Hojong Yoon et al. · ACS Medicinal Chemistry Letters · 2020 · 48 citations · Full text

, , +14

1–5 of 19